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Introduction: The high frequencies of carriers of severe haemoglobinopathies and
of iron deficiency in Southeast Asia require reliable and affordable tests to improve on
current screening procedures.
Objectives: We evaluate a “one stop” approach using the THALCON
dichlorophenolindophenol (DCIP) and one-tube osmotic fragility (OF) tests and
measurement of Zinc Protoporphyrin (ZPP) to detect and distinguish HbE and
β-thalassaemia traits from iron deficiency. We compare findings with current screening
practice in Sri Lanka that relies on the identification of low mean red cell volume and/or
mean red cell hemoglobin for this purpose.
Methods: Between November 2017 and May 2018, we undertook a cross-sectional
survey of secondary school students in Gampaha district, Sri Lanka. The
THALCON–DCIP and OF tests were compared to capillary electrophoresis (CE),
used as a gold standard to detect haemoglobinopathies. ZPP was measured in whole
blood. Plasma ferritin and C-reactive protein (CRP) were measured in students with a
raised ZPP concentration.
Results: We collected venous blood samples from 1,324/1,332 (99.4%) students. The
median age of the students was 17 (IQR 16–18) years, all were Sinhalese and 814/1,324
(61.5%) were female. CE identified 3 students with HbE trait and 26 students with
β-thalassaemia trait. The THALCON–DCIP test was positive only in the 3 students with
HbE (sensitivity 100%, 95% CI 29.2–100.0; specificity 100%, 95% CI 99.7–100.0). The
THALCON–OF test identified all 26 students with β-thalassaemia trait (sensitivity= 100%,
95% CI 86.8–100.0) and 287 students with a normal CE result (specificity= 77.9%; 95%
CI 75.5–80.1). It was also positive in 2/3 (66.7%) students with HbE trait. Iron deficiency
(ZPP > 70 µmol/mol heme) was present in 118/1,240 (9.5%) students with a normal
hemoglobin genotype, all of whom had plasma ferritin <15 ng/ml and CRP <5 mg/L.
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Conclusion: This one–stop approach offers reliable and affordable population screening
for both haemoglobinopathy traits and iron deficiency in resource-limited settings where
these conditions are common and ensures that iron supplements are targeted only to
those who require them. Further work is warranted to refine the OF test to reduce the
number of false positive results.
Keywords: haemoglobinopathy traits, iron deficiency, osmotic fragility, dichlorophenolindophenol, red cell indices
INTRODUCTION
It is estimated that >7% of the world’s population carry a
hemoglobin variant, resulting in 300,000–500,000 babies born
each year with a significant hemoglobin disorder. Ninety percent
of these births occur in low or middle-income countries
(Weatherall, 2010). Hemoglobin disorders are estimated to
account for at least 3.4% of under-five deaths (Modell and
Darlison, 2008).
A recent survey of 23 thalassaemia treatment centers
in Sri Lanka identified 1,219 patients with β-thalassaemia
major, 360 with HbE/β-thalassaemia, and 50 with sickle β-
thalassemia (A Premawardhena, personal communication).
Patients with β-thalassaemia major require life-long intensive
clinical management and monthly blood transfusion (now
referred to as transfusion-dependent thalassaemia TDT). The
clinical course of HbE/β-thalassaemia is more variable, ranging
from mild (non-transfusion dependent thalassaemia NTDT)
to severe anemia. In both conditions, in the absence of
early and effective iron-chelation therapy, transfusional iron
overload may result in liver and cardiac dysfunction, and
endocrine abnormalities including growth disturbances and
glucose intolerance. Often, patients experience a severely reduced
quality of life, suffer from social stigmatization, and may have
difficulties in securing employment. In higher-resource settings,
survival now extends to the fifth or sixth decade, but this is not
true in lower income settings where the costs and complexities of
care mean that survival is curtailed (Cunningham et al., 2004).
The cost of care for thalassaemia in Sri Lanka is estimated
to be more than 5% of the national health budget each year
(de Silva et al., 2000). In a survey of 7,526 school children in Sri
Lanka, the frequency of β-thalassaemia and HbE traits varied
from 0.0 to 8.1% and 0.0 to 1.9%, respectively, according to
district (Premawardhena et al., 2017).
Iron deficiency is the most common micronutrient disorder
and causes anemia in up to 30% of individuals throughout the
world. In adolescents, anemia impairs school performance and
resistance to infection (WHO/UNICEF/UNU Iron deficiency
anaemia: Assessment, Prevention and Control, 2001; Black, 2003;
Zimmerman and Hurrell, 2007). In the above survey of Sri
Lankan school children and adolescents, the frequency of iron
deficiency was 19.2% (Allen et al., 2017).
A national haemoglobinopathy screening programme began
in Sri Lanka in 2005 with the goal of reducing births of severely
affected children. The screening programme targets school
children, adolescents and young people, to allow individuals
to make informed choices regarding future marriage partners
and child-bearing. In view of the high cost of the definitive
tests for haemoglobinopathy detection (Capillary Electrophoresis
(CE), high-performance liquid chromatography and DNA
analysis), in Sri Lanka, as in many Asian countries, population
screening relies on detecting low mean red cell volume and/or
mean red cell hemoglobin (hereafter “low red blood cell
indices”) to identify possible carriers of haemoglobinopathies
who require further investigation. However, this approach has
several limitations. Reliable measurement of red cell indices
requires automated hematology analysers that are maintained
and calibrated regularly, with quality controls run daily.
Accuracy may vary according to the instrument used. Low
red cell indices also occur in iron deficiency, complicating
differentiation from haemoglobinopathy traits. Finally, red
cell indices may be normal in carriers of unusually mild
β-thalassaemia alleles and in HbE trait (Weatherall, 2001;
Fucharoen et al., 2004; Sanchaisuriya et al., 2005; Galanelo, 2012;
Singha et al., 2019) and in people who inherit more than one
haemoglobinopathy trait (e.g., α-thalassaemia together with β-
thalassaemia (Penman et al., 2015).
The DCIP and OF tests have been proposed as simple
visual screening tests for the detection of carriers of HbE and
β-thalassaemia, respectively (Sanchaisuriya et al., 2005). The
DCIP test, first described in 1976 (Kulapongs et al., 1976), is
based on the principle that HbE is an unstable hemoglobin
that when added to the blue dye dichlorophenolindophenol,
at neutral pH, is oxidized, forming a precipitate (Kulapongs
et al., 1976; Old, 2012). In the OF test, thalassaemic red
blood cells are more resistant to haemolysis than normal
red blood cells because of their small size and low cellular
hemoglobin content, and when added to hypotonic buffered
saline, typically of 0.36% (w/v) concentration, produce a turbid
solution (Parpart et al., 1947; Winichagoon et al., 2002; Old,
2012; Ansari et al., 2014). Both the DCIP and OF tests have
been successfully used as screening tests in Thailand since
1990, and reagents available in kit form have been developed
and extensively validated. In previous studies, the sensitivity
and specificity of the tests when used in combination for the
detection of HbE and β-thalassaemia traits ranged between
99.2 and 100% and 79.3–97.1%, respectively (Sangkitporn et al.,
2005; Savongsy et al., 2008; Viprakasit and Ekwattanakit,
2018).
We have evaluated the THALCON-DCIP and THALCON-
OF tests in 60 parents of patients with either β thalassaemia or
HbE/β- thalassaemia attending the Thalassemia Care Unit, North
Colombo Teaching Hospital, Ragama, Sri Lanka. The DCIP test
identified all 15 parents with HbE-trait. The OF test correctly
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identified all 45 parents with β-thalassaemia trait and was also
positive in 5/15 HbE traits. There were no false negatives in
either test.
The ZPP test is based on the principle that during the final
stage of heme synthesis in the bone marrow, if the iron supply
is limited or unavailable, zinc, instead of iron, is incorporated
into the protoporphyrin ring of the hemoglobin molecule and
accumulates in red blood cells (WHO, 2007). The World Health
Organization recognizes the usefulness of ZPP as a screening test
for iron deficiency in population surveys in low–resource settings
(WHO, 2007), and ZPP was used to identify iron deficiency in
one of the largest randomized control studies of iron supplements
in children in Zanzibar (Sazawal et al., 2006).
We took the opportunity to join the national
haemoglobinopathy screening program during its annual
survey of secondary schools in Gampaha district, Sri Lanka
to evaluate the THALCON-DCIP and THALCON–OF test
kits and the measurement of ZPP as a “one-stop” screening
procedure for the detection of haemoglobinopathy traits and
iron deficiency. We compared this approach to the measurement
of low red cell indices, the test currently used by the national
screening program.
METHODS
School Surveys
Between November 2017 and May 2018 we recruited students
attending 9/172 secondary schools with Advanced Level classes
from Gampaha district, Sri Lanka. Schools were purposefully
selected so that they were geographically spaced within the
Gampaha district. Study personnel visited each school to explain
the purpose of the study to students and teachers. All students
in grades 10–13 (>14 years of age) were invited to partake.
Signed, informed consent was obtained from parents/guardians;
all students also provided verbal consent. Any student who
reported feeling un-well on the day of the survey was not enrolled
into the study. Approximately 150 students, drawn from across
the four school years were enrolled from each school. Age, sex,
ethnicity, and place of residence were recorded. In students with
mixed ethnicity, that of the father was recorded.
Laboratory Procedures
A 2.5ml venous blood sample was collected into EDTA
anticoagulant from each student. Samples were stored in a cool
box and transferred to the laboratory within 3 h of collection
for measurement of hemoglobin concentration, red cell indices
(Beckman Coulter Ac.T diff analyser, Luton, UK), detection
of hemoglobin variants by CE (Capillarys 2 Flex Piercing
Instrument, Sebia, Lisses, France), and the THALCON- DCIP
and THALCON-OF tests (Surathin International Company Ltd.,
Thailand), in accordance with the manufacturer’s guidelines.
Briefly, for the DCIP test, 20 µl whole blood was added to
2ml DCIP solution, gently mixed by inversion and incubated at
37◦C for 15min. 20 µl of clearing solution was then added to
each reaction and the results interpreted immediately. For the
THALCON-OF test, 20 µl whole blood was added to 2ml of a
0.36% buffered saline solution, gently mixed by inversion and
incubated at room temperature for 5min before the results were
read. In both tests, a turbid pink solution indicated a positive
result and a clear pink solution indicated a negative/normal result
(see Figure 1). Positive and negative control blood samples were
included for each set of tests.
ZPP was measured in whole blood using a front-faced
haematofluorimeter and Protofluor reagent system (Helena
BioSciences, South Shields, UK). The remaining samples were
centrifuged, the buffy coats and plasma removed and stored
at −20◦C for further analyses. Plasma CRP and ferritin were
measured by Enzyme Linked Immunosorbent assay (DCRP00,
Biotechne, UK andDB59111, Tecan, UK, respectively) in samples
with a raised ZPP to confirm iron deficiency and to explore
whether inflammation may have resulted in a raised ZPP result.
To investigate possible causes of a positive OF test in samples
with a normal CE result, DNA was extracted from buffy coat
samples using QIAGEN DNA mini-kit (QIAGEN, UK) and
α- globin genotype determined by Multiplex polymerase chain
reaction (Tan et al., 2001; Shaji et al., 2003).
Statistical Methods
Categorical variables were summarized using counts and
percentages. Continuous variables tended to have skewed
distributions; they were described usingmedian and interquartile
FIGURE 1 | The clear pink solution observed in the tube on the left indicates a
normal test result, whereas the turbid pink appearance of the tube on the right
indicates a positive test result.
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range and compared using the Mann-Whitney U test. Sensitivity
and specificity and the corresponding 95% confidence intervals
(CI) of the DCIP and OF tests were calculated with capillary
electrophoresis (CE) as the gold standard. Considering the small
number of positive results for the DCIP test, the exact 95% CIs
were obtained. All the estimates whose corresponding 95%CI did
not span 50% (i.e., proportion= 0.5) were considered significant
and all tests were performed at 5% significance level. All data
analysis was performed using SPSS statistical software version 25.
Ethical Approval
The study and the consent procedures were approved by the
Ethics Committee, University of Kelaniya, Sri Lanka and Oxford
University Tropical Research Ethics Committee, Oxford, UK.
The study was conducted in accordance with the declaration of
World Medical Association (2008).
RESULTS
A total of 1,332 students were enrolled and venous blood samples
were collected from 1,324 (99.4%). The 8 students for whom it
was not possible to obtain a blood sample have been excluded
from the analysis. The median age of the students was 17
(IQR 16–18) years; all were Sinhalese and 814/1,324 (61.5%)
were female.
The sensitivity and specificity for the screening tests are
shown in Table 1. Laboratory findings according to hemoglobin
genotype and sex are shown in Supplementary Table S1.
Haemoglobinopathy Traits
CE identified hemoglobin variants in 29 (2.2%) students. Three
students were HbE trait and the DCIP test was positive only in
these 3 samples (sensitivity= 100%, 95% confidence interval (CI)
29.2–100.0; specificity= 100%, 95% CI 99.72–100.0). Twenty-six
students had raised HbA2, indicative of β-thalassaemia trait. The
OF test correctly identified all 26 students with β-thalassaemia
trait but was also positive in 287 samples with normal CE results
(sensitivity= 100%, 95% CI 86.8–100.0; specificity= 77.9%, 95%
CI 75.5–80.1). The OF test was also positive in 2 of 3 students
with HbE trait. Overall, in the detection of either β-thalassaemia
trait or HbE trait, the combination of the DCIP and OF tests had
a sensitivity of 100% (95% CI 88.1–100.0) and specificity of 77.8%
(95% CI 75.5–80.1).
Low Red Cell Indices
Low red cell indices (mean cell volume (MCV) <80 fl or mean
cell hemoglobin (MCH) < 27 pg) were present in all 26 students
with β-thalassaemia trait and the 3 students with HbE trait but
were also present in 409/1,293 (31.6%) students with a normal
CE result (sensitivity = 100%; 95% CI 88.1–100.0; specificity =
68.4%, 95% CI 65.8–70.9).
Iron Deficiency
ZPP was raised (>70 µmol/mol heme) in 141/1,314 (10.7%)
students including 14/26 (53.8%) with β-thalassaemia trait
and 9 students with α-thalassaemia trait. In 118/1,240 (9.5%)
students with a normal hemoglobin genotype and raised ZPP,
TABLE 1 | Sensitivity and specificity of screening tests for haemoglobinopathy
traits compared to capillary electrophoresis as the gold standard.
Test Capillary
electrophoresis
Sensitivity
(95% CI)
Specificity
(95% CI)
Pos Neg
Capillary electrophoresis
HbE trait 3 1,321
β-thalassaemia trait 26 1,298 - -
HbE trait or
β-thalassaemia trait
29 1,295
Thalcon DCIP test (HbE) Pos 3 0 100.0 100.0
Neg 0 1,321 (29.2–100.0) (99.7–100.0)
Thalcon OF test
(β-thalassaemia trait)*
Pos 26 287 100.0 77.9
Neg 0 1,009 (86.8–100.0) (75.5–80.1)
Thalcon DCIP and
Thalcon OF
Pos 29 287 100.0 77.8
Neg 0 1,008 (88.1–100.0) (75.5–80.1)
Low red cell indices
(MCV<80 fl or MCH <
27 pg)
Pos 29 409 100.0 68.4
Neg 0 884 (88.1–100.0) (65.8–70.9)
*The two students with HbE trait and positive OF test are excluded.
all had normal plasma CRP (<5 mg/L) and low plasma ferritin
concentrations (<15 ng/ml), confirming iron deficiency.
In the 14 students with β-thalassaemia trait and raised ZPP,
plasma CRP was normal in 12/14 (85.7%) and ferritin in 13/14
(92.9%); only one student had iron deficiency.
Sufficient plasma was available to measure CRP and ferritin
in 8/9 students with α-thalassaemia trait and a raised ZPP. Iron
deficiency was confirmed 7/8 (87.5%) students; one student had
a normal plasma ferritin and a raised CRP.
ANALYSIS OF UNEXPLAINED-POSITIVE
OF TESTS
α-globin Genotype
Amongst the 287 students with an unexplained positive OF
result, sufficient DNA was available to determine α-globin
genotype in 286/287 (99.7%). Forty-five students had α-
thalassaemia; 35 with -α3.7/ αα, 4 with -α3.7 /-α3.7 and 6 with
–α4.2/ αα. The less common α-globin gene mutations – –SEA,
– –FIL, – –MED, – –THAI, – α−20.5 were not present in any sample.
Low Red Cell Indices and Anemia
Mean cell volume, mean cell hemoglobin and hemoglobin
concentration were measured in 235/242 (97.1%) of the
remaining students with an unexplained positive OF test, and
median values were similar to those of 1,005 students with a
true negative OF result (Figures 2A–D). However, the frequency
of low red cell indices and of anemia in the two groups were
significantly different (85/235 (36.2%) and 280/1,005 (27.9%; p=
0.0137), respectively for low red cell indices and 75/235 (31.9%)
and 202/1005 (20.1%; p= 0.0002) for anemia.
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FIGURE 2 | Median (IQR) MCV (A) and MCH (B) were similar in 235 students with an unexplained positive OF result and 1,005 students with a true negative OF
result: 82.0 fl (77.0–84.0) and 27.8 pg (25.7–28.6) vs. 82.0fl (80.0–85.0) and 28.0 (26.9–29.0), respectively. Median (IQR) Hb was 14.4 g/dl (13.6–15.2) and 12.0 g/dl
(10.9–12.8) in 96 males (C) and 139 females (D), respectively, with an unexplained positive OF result vs. 14.5 g/dl (13.8–15.4) and 12.5 g/dl (11.9–13.1) in 383 males
and 622 females with a true negative OF result. Median (IQR) ZPP was similar in 235 students with an unexplained positive OF result and 1,005 with a true negative
OF result; 44 µmol/mol heme (add IQR) and 43 µmol/mol heme (add IQR), respectively (E). Horizontal lines inside the box show the median value, box length is the
interquartile range and whiskers show the range, excluding outliers. Outlying values 1.5–3, or > 3 box lengths from the upper and lower edge of the box are shown as
open circles and stars, respectively. Reference lines shows the lower limit of the normal range for MCV, MCH, and Hb and the upper limit of the normal range for ZPP.
Iron Deficiency
Median ZPP was similar in 235 students with an unexplained
positive OF result and 1,005 with a true negative OF result;
44 µmol/mol heme and 43 µmol/mol heme, respectively
(Figure 2E). However, the frequency of raised ZPP was greater
in students with an unexplained positive OF test (47/235;
20.0%) than those with a true negative result (77/1,005;
7.7%; p < 0.0001).
DISCUSSION
The THALCON-DCIP and THALCON-OF tests performed
well in our hands, were quick and easy to use and required
minimal laboratory equipment. The inclusion of a clearing
agent in the DCIP kit, used to decolorize the blue DCIP dye
at the end of the incubation period, allowed the tests to be
read easily.
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Although the THALCON–DCIP test had 100% sensitivity and
specificity for carriers of HbE, the low number of cases in our
study resulted in a wide 95% confidence interval for sensitivity
(29.2–100.0). Low red cell indices, the current screening criteria
used in Sri Lanka, also identified all HbE carriers in this
study. However, low red cell indices are not always a feature
of HbE trait, and we have reported previously that in a larger
survey of 7,526 secondary school students in Sri Lanka, red cell
indices were normal in 3/38 (7.9%) of students with HbE trait
(Premawardhena et al., 2017). Similarly, in a study of pregnant
women in Thailand, 14/93 (15.5%) HbE traits had normal red
cell indices (Sanchaisuriya et al., 2005). Further evaluation of the
THALCON–DCIP test in populations with a low frequency of
HbE carriage will require large numbers. For example, In Sri
Lanka where the overall prevalence of HbE trait is 0.23%, with
a lower 95% confidence limit for sensitivity to be >90% and
0.80 probability, a sample size of 18,261 participants would be
required and 53,479 participants would be required for the lower
95% confidence limit for sensitivity to be >95%.
The THALCON-OF test identified all carriers of
β-thalassaemia, and the greater prevalence of this
haemoglobinopathy in Sri Lanka allowed a more reliable
assessment of sensitivity (95% CI 86.8–100.0). Use of low red cell
indices had a similar sensitivity. Although the THALCON-OF
test identified many false positives (specificity 77.9%; 95% CI
75.5–80.1), specificity was better than when using low red cell
indices (specificity = 68.4%; 95% CI 65.8–70.9). Using low red
cell indices would have resulted in 438/1,322 (33.1%) samples
requiring expensive confirmatory tests compared to 315/1,324
(23.7%) with the OF test (representing approximately 30%
fewer tests).
Although ZPP can be raised in conditions other than iron
deficiency, such as inflammation and some haemoglobinopathies
(Thomas et al., 1977; Labbé, 1992; WHO, 2007; Parischa
and Drakesmith, 2016), we found that the inclusion of ZPP
measurement in this study was helpful in identifying students
who were truly iron deficient as confirmed by reduced
plasma ferritin and normal CRP concentrations, excluding
inflammation. However, we did not measure CRP and ferritin
in students with a normal ZPP and it is possible that some
students with earlier stages of iron deficiency may have been
missed. Raised ZPP is also useful in idenitfying people with
lead poisoning (Thomas et al., 1977; Labbé, 1992; WHO, 2007;
Parischa and Drakesmith, 2016); however, this is unlikely to be
common in Sri Lanka following the introduction of unleaded
petroleum in 2002 (Senanayake et al., 2004).
Almost one third of this study population had low red cell
indices. Because low indices are a feature of both iron deficiency
and some haemoglobinopathy traits, current screening practice
in Sri Lankameans that staff are often faced with a dilemma when
deciding on further investigations to identify the cause of the low
indices. In addition, we have reported that low red cell indices not
attributable to either iron deficiency or haemoglobinopathy traits
are also common in this population (Allen et al., 2017; Rodrigo
et al., 2018). Because the definitive tests for haemoglobinopathy
traits are expensive and iron deficiency is more common in
Sri Lanka, screening staff recommend that individuals with low
indices repeat their full blood count after a 3–6 month course of
oral iron, to exclude iron deficiency as the cause. If at follow-
up the red cell indices remain low, the definitive test is then
performed. Based on these current screening procedures, in
this study, iron supplements would have been recommended
to 438 (33.1%) students with low red cell indices. However, by
measuring ZPP in combination with the DCIP and OF tests in a
one-stop procedure this number would be reduced to 77/1,005
(7.7%) students, representing a considerable saving. Moreover,
the risk of loss to follow-up that occurs with current screening
practice would be limited. Avoiding the unnecessary use of iron
supplements is important given that tolerance of oral iron is
poor and iron increases the risk of infection (Murray et al.,
1978; Drakesmith and Prentice, 2012; Kortman et al., 2012).
Furthermore, the high frequency of the H63D variant of the
haemochromatosis gene and the presence of haemoglobinopathy
traits in Sri Lanka (Premawardhena et al., 2017; Allen et al.,
2019) mean that it is important to ensure that iron supplements
are targeted to only those who require them, to avoid the
possible deleterious effects of increased iron availability in iron
replete individuals.
Although our numbers were small, ZPP appeared to be a
reliable marker of iron deficiency in α-thalassaemia but not in
β-thalassaemia traits. Our findings in β-thalassaemia trait are
concordant with other studies but are discordant with studies for
α-thalassaemia (Tillyer and Tillyer, 1994; Graham et al., 1996).
Additonal confirmatory tests for iron deficiency are required for
students with haemoglobinopathy traits before recommending
iron supplements.
Consistent with other studies of OF (Kattamis et al., 1981;
Jopang et al., 2009), we observed a significant number of false
positive results with the THALCON-OF test. DNA analysis
confirmed that α-thalassaemia accounted for the positive OF
result in about 20%, and low red cell indices, anemia or iron
deficiency may also have contributed. It is possible that the
concentration of saline used in the test (0.36%) was too high for
the complete lysis of normal red blood cells, and using a weaker
saline solution may have reduced the number of false positives.
Supporting this hypothesis is a study of haemoglobinopathy
traits in a rural population of Thai Khmer, in which a buffered
saline solution of 0.34% reduced OF false positivity without
compromising the sensitivity of the test (Fucharoen et al., 2004).
We consider that the combination of the OF, DCIP, and ZPP
assays is a useful approach to screening for haemoglobinopathy
traits and iron deficiency in population surveys in Sri Lanka, and
has several advantages over the use of low red cell indices alone.
These findings are directly relevant to populations in other low
andmiddle-income countries in which haemoglobinopathies and
iron deficiency are common. The study was conducted under
research conditions by trained laboratory staff, and now needs
to repeated in routine and remote settings, where laboratory
expertise may be variable.
Regardless of the screening methods used, there is a
pressing need to establish external quality assessment (EQA)
programmes to monitor how well the tests are performed and
interpreted by local staff, to ensure the accuracy and success
of all haemoglobinopathy screening programmes. Indeed, an
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EQA programme implemented in Thailand has been shown
to improve the performance of many screening laboratories
(Prommetta et al., 2017).
CONCLUSION
A combination of OF, DCIP, and ZPP assays improves upon
current screening procedures for haemoglobinopathy traits that
are currently based on identification of low red cell indices, and
also identifies iron deficiency in a one-stop procedure. Further
work should be undertaken to refine the OF assay in an effort
to reduce the number of false positives. Further research should
evaluate the performance and cost effectiveness of this one-stop
approach in routine and remote laboratory settings.
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